FRIDAY, April 24 (HealthDay News) — Simponi (golimumab) has been approved by the U.S. Food and Drug Administration to treat three forms of arthritis that occur when the body’s immune system attacks the joints.
Arthritis Information
Arthritis Information
FRIDAY, April 24 (HealthDay News) — Simponi (golimumab) has been approved by the U.S. Food and Drug Administration to treat three forms of arthritis that occur when the body’s immune system attacks the joints.
